ATN Radionuclide Imaging in Dementia: Amyloid, Tau, and FDG PET

DOI
  • KATO Takashi
    Department of Radiology, National Center for Geriatrics and Gerontology Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology
  • OKADA Yusuke
    Department of Psychiatry, National Center for Geriatrics and Gerontology
  • NIHASHI Takashi
    Department of Radiology, National Center for Geriatrics and Gerontology
  • SAKURAI Keita
    Department of Radiology, National Center for Geriatrics and Gerontology
  • KIMURA Yasuyuki
    Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology
  • ITO Kengo
    Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology

Bibliographic Information

Other Title
  • 認知症のATN 核医学画像診断―アミロイド，タウ，FDG PET―

Description

<p>In the field of imaging diagnosis of dementia, the concept of imaging biomarkers has proposed the research criteria of ATN classification corresponding to amyloid （A）, tau （T）, and neurodegeneration （N）. The use of amyloid PET （A）, tau PET （T）, and FDG cerebral glucose metabolism PET （N） as imaging biomarkers will enable ATN classifica tion and is expected to contribute to the differential diagnosis of dementia and the elucidation of the progression process of Alzheimerʼs disease.</p>

Journal

  • Medical Imaging Technology

    Medical Imaging Technology 40 (3), 88-94, 2022-05-25

    The Japanese Society of Medical Imaging Technology

Keywords

Details 詳細情報について

  • CRID
    1390013032133224064
  • DOI
    10.11409/mit.40.88
  • ISSN
    21853193
    0288450X
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top